UAE Mammography Devices Market Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product Type (Full-Field Digital Mammography, Film-Screen Mammogram, Breast Tomosynthesis), By Technology (Digital, Analog), By End User (Hospitals & Clinics, Diagnostic Centers, Others), by region, and Competition 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 26.61 Million
CAGR (2026-2031)	11.19%
Fastest Growing Segment	Digital
Largest Market	Abu Dhabi
Market Size (2031)	USD 50.29 Million

Market Overview

The UAE Mammography Devices Market will grow from USD 26.61 Million in 2025 to USD 50.29 Million by 2031 at a 11.19% CAGR. Mammography devices utilize low-energy X-ray technology to visualize breast tissue for the screening, early detection, and diagnosis of malignancies. The market in the United Arab Emirates is primarily driven by proactive government initiatives aimed at increasing screening participation and the continuous expansion of healthcare infrastructure to meet international standards. Furthermore, the rising incidence of breast cancer necessitates the extensive procurement of diagnostic equipment, ensuring consistent demand across both public and private medical sectors.

Nevertheless, the high acquisition and maintenance costs associated with advanced digital imaging systems present a significant challenge that could impede market expansion, particularly for smaller healthcare providers with limited capital. This financial barrier restricts the widespread adoption of premium technologies despite the growing clinical need. According to the International Agency for Research on Cancer, in 2024, breast cancer accounted for approximately 21 percent of all new cancer cases reported in the UAE.

Key Market Drivers

The implementation of national breast cancer screening programs serves as a critical driver for the UAE Mammography Devices Market, fundamentally boosting the demand for diagnostic equipment. Government entities are actively expanding access to preventive care through strategic partnerships and mandated health screenings, which has significantly elevated patient turnover in radiology departments. This proactive regulatory environment compels healthcare facilities to upgrade their fleets to accommodate the growing volume of participants in early detection initiatives. According to the Abu Dhabi Public Health Centre, October 2025, in the 'Check What Really Matters' campaign report, the number of breast cancer screenings in the emirate rose by 31 percent in 2024, reaching over 34,000 women.

Concurrently, the integration of Artificial Intelligence in breast imaging is accelerating the adoption of premium mammography systems across the Emirates. Medical centers are prioritizing AI-enhanced devices to improve diagnostic precision, particularly for detecting subtle lesions in dense tissue that conventional 2D modalities may overlook. This technological evolution not only streamlines clinical workflows but also significantly improves patient outcomes by minimizing false negatives. According to HealthBay Vitalia, October 2025, in the announcement regarding the launch of the UAE’s first Genius AI-integrated mammography system, the new technology is projected to detect 20 to 65 percent more invasive breast cancers than traditional imaging methods. This technological uptake is essential to address the growing disease burden; according to Emirates Health Services, in 2025, the prevalence of breast cancer in the UAE reached 94 cases for every 100,000 women.

Download Free Sample Report

Key Market Challenges

The high capital and operational costs required to procure and maintain advanced mammography systems constitute a primary barrier to the growth of the UAE market. High-performance digital imaging units demand heavy investment, often exceeding the budgetary capacities of smaller, independent medical facilities. These clinics, operating with limited financial reserves, are frequently unable to justify the high acquisition and ongoing maintenance expenses associated with premium diagnostic technologies. Consequently, the market remains largely confined to well-funded government hospitals and major private chains, significantly capping the total sales volume and slowing the rate of technology adoption across the sector.

This concentration of purchasing power narrows the addressable market for device manufacturers. The inability of smaller providers to enter the diagnostic space prevents the industry from capitalizing on the region's extensive healthcare infrastructure. For instance, according to the Department of Health – Abu Dhabi, in 2024, there were over 1,520 medical centers operating in the Emirate compared to a much smaller number of full-scale hospitals. The financial exclusion of this vast segment of smaller facilities effectively restricts equipment vendors to a fraction of the potential client base, directly hampering the broader expansion and penetration of the mammography devices market.

Key Market Trends

The Expansion of Mobile Mammography Screening Units for Remote Access is reshaping the UAE market by decentralizing diagnostic services and reaching underserved populations beyond major urban centers. Healthcare providers and non-profit organizations are increasingly deploying advanced mobile clinics equipped with digital mammography systems to workplaces, universities, and remote communities, effectively eliminating geographical and logistical barriers to early detection. This outreach strategy allows for mass screening campaigns that capture a demographic otherwise unlikely to visit fixed hospital facilities, thereby feeding the patient pipeline for further diagnostic and treatment services. According to the Emirates News Agency, November 2025, in the 'FOCP concludes Pink October 2025' report, the Pink Caravan initiative successfully delivered 19,527 free breast cancer screenings across the nation through its expanded fleet of fixed and mobile clinics.

Simultaneously, the market is witnessing a Shift Toward Density-Based Personalized Breast Cancer Screening Protocols, moving away from standard age-based guidelines to tailored approaches that account for individual risk factors like breast density. Medical facilities are integrating supplementary imaging modalities, such as ultrasound and MRI, into screening pathways for women with dense breast tissue, where traditional mammography may lack sensitivity. This personalized strategy enhances diagnostic precision and ensures that high-risk profiles are managed with more rigorous surveillance, reducing the rate of missed malignancies. According to the Burjeel Cancer Institute, April 2025, in the 'Burjeel Breast Center Launch' announcement, the facility performed over 22,000 screening and diagnostic exams in 2024, utilizing advanced density-adjusted protocols to optimize patient outcomes.

Segmental Insights

Digital mammography is currently identified as the fastest-growing segment within the UAE mammography devices market. This expansion is primarily driven by the increasing demand for high-throughput diagnostic tools that support national screening initiatives led by the Ministry of Health and Prevention. Healthcare facilities are prioritizing digital systems because they allow for immediate image acquisition and seamless integration with electronic medical records, significantly improving clinical workflow. Furthermore, the shift away from analog systems is accelerated by the need for enhanced diagnostic accuracy, ensuring earlier detection and better patient outcomes across the Emirates.

Regional Insights

Abu Dhabi holds the leading position in the UAE Mammography Devices Market, primarily due to substantial government investment in preventative healthcare infrastructure. This dominance is underpinned by the Department of Health - Abu Dhabi (DoH), which enforces rigorous cancer screening standards, including mandatory biennial mammograms for women aged forty and above. Furthermore, the Abu Dhabi Public Health Centre actively drives demand through strategic early detection initiatives and public awareness programs. These regulatory frameworks have accelerated the adoption of advanced digital imaging technologies across the emirate's network of medical cities and hospitals, sustaining a strong market for diagnostic solutions.

Recent Developments

• In October 2025, HealthBay Vitalia inaugurated a specialized Breast Clinic in Jumeirah, featuring the deployment of the Hologic 3Dimensions mammography system integrated with Genius AI Detection. This launch represented a significant technological advancement in the UAE's private healthcare sector, providing patients with high-resolution 3D images and faster processing times for breast cancer screening. The integration of artificial intelligence was designed to assist radiologists in detecting subtle lesions with greater accuracy while simultaneously reducing the rate of false positives. This development underscored a growing trend towards adopting AI-driven diagnostic tools to improve early detection rates and patient outcomes in the region.
• In January 2025, GE HealthCare unveiled its latest mammography innovation, the Pristina Via system, during the Arab Health exhibition held in Dubai. This advanced system was introduced to the Middle East market to enhance the breast screening experience for both patients and technologists by offering features such as zero-click acquisition and vendor-neutral prior image comparison. The launch highlighted the company's focus on improving diagnostic accuracy and operational efficiency in breast imaging workflows. By showcasing this technology at the region's premier healthcare event, the company reinforced its commitment to providing sophisticated precision care solutions to UAE healthcare providers.
• In October 2024, Burjeel Holdings launched the "Scan for Life" campaign, a strategic initiative focused on increasing the accessibility of breast cancer screenings across the United Arab Emirates. As a core component of this program, the healthcare group deployed a mobile mammography truck equipped with advanced imaging technology to visit various high-traffic locations, including shopping malls and corporate offices. The mobile unit facilitated complimentary screenings for women, particularly targeting those in high-risk age groups. This operational expansion was intended to remove barriers to healthcare access, ensuring early detection through convenient, high-quality diagnostic services brought directly to the community.
• In April 2024, American Hospital Dubai introduced a contrast-enhanced breast biopsy technique at its Breast Care Clinic, establishing a new diagnostic standard among private healthcare providers in the region. This advanced procedure was designed to integrate traditional biopsy methods with contrast agents, significantly enhancing the visibility of suspicious lesions that might remain undetected during standard mammograms or ultrasound examinations. The initiative aimed to elevate diagnostic precision and patient care outcomes by offering a highly accurate alternative to MRI-guided biopsies, thereby strengthening the facility's capabilities in the early detection and management of breast cancer within the UAE market.

Key Market Players

• Siemens Healthineers UAE
• GE Healthcare FZE
• Philips Healthcare Middle East
• Canon Medical System UAE
• Fujifilm Middle East FZE
• Carestream UAE
• Konica Minolta UAE
• Hologic UAE

By Technology	By End User	By Region
Digital Analog	Hospitals & Clinics Diagnostic Centers Others	Dubai Abu Dhabi Sharjah Rest of UAE

Report Scope:

In this report, the UAE Mammography Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Mammography Devices Market, By Technology:

• Digital
• Analog

• UAE Mammography Devices Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Others

• UAE Mammography Devices Market, By Region:

• Dubai
• Abu Dhabi
• Sharjah
• Rest of UAE